Tac-an, Sherilyn .

HRN: 01-75-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
AMPICILLIN 1GM (VIAL)
12/25/2022
12/26/2022
IV
2gm
Q6
PROM X 6HRS
Waiting Final Action 
12/26/2022
CEFUROXIME 500MG (TAB)
12/26/2022
01/01/2023
PO
500mg
BID
S/P RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: